HALISTER1: Valeant Says 5 Independent Directors Won’t Stand for Re-Election

Valeant Says 5 Independent Directors Won’t Stand for Re-Election

(Bloomberg) -- Valeant says 5 independent directors informed board that they won’t stand for re-election at 2016 annual meeting: Ronald H. Farmer, Colleen Goggins, Theo Melas-Kyriazi, G. Mason Morfit and Norma A. Provencio.
  • Board has recommended 3 additional independent directors: Argeris N. Karabelas, partner at Care Capital venture firm; Russel C. Robertson, EVP and head of anti-money laundering at BMO; and Amy B. Wechsler, a New York dermatologist
  • Other nominees for election are new CEO Joseph Papa, Robert A. Ingram, Robert N. Power, and 5 current independent directors who were appointed in the last year: Bill Ackman, Frederic Eshelman, Stephen Fraidin, D. Robert Hale, Thomas W. Ross, Sr.
  • VRX stock opening delayed for news
  • NOTE: Earlier, Valeant Receives New State Investigation Probes Link; Files 10-K Ahead of Creditor Deadline Link
Statement Link
Alert: HALISTER1
Source: BFW (Bloomberg First Word)

Tickers
VRX CN (Valeant Pharmaceuticals International Inc)

People
Argeris Karabelas (Care Capital LLC)
Russel Robertson (Harris Financial Group)
Joseph Papa (Perrigo Co PLC)

Topics
Who's News - People

To de-activate this alert, click here

UUID: 7947283